NCT05315544 - Cardiovascular Systems Inc. (CSI) pVAD First in Human Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 14, 2022

Primary Completion Date

March 16, 2022

Study Completion Date

March 16, 2022

Conditions

Coronary Artery Disease

Interventions

DEVICE

CSI pVAD system

The CSI percutaneous ventricular assist device (pVAD) is being investigated as a temporary left ventricular system intended to support and/or provide hemodynamic stability during high-risk percutaneous coronary interventions.

Trial Locations (1)

Unknown

Tbilisi Heart & Vascular, Tbilisi